"Lipopeptides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds consisting of a short peptide chain conjugated with an acyl chain.
| Descriptor ID |
D055666
|
| MeSH Number(s) |
D10.477 D12.644.365
|
| Concept/Terms |
Anionic Lipopeptides- Anionic Lipopeptides
- Lipopeptides, Anionic
- Anionic Lipopeptide
- Lipopeptide, Anionic
Cationic Lipopeptides- Cationic Lipopeptides
- Lipopeptides, Cationic
- Cationic Lipopeptide
- Lipopeptide, Cationic
|
Below are MeSH descriptors whose meaning is more general than "Lipopeptides".
Below are MeSH descriptors whose meaning is more specific than "Lipopeptides".
This graph shows the total number of publications written about "Lipopeptides" by people in this website by year, and whether "Lipopeptides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2009 | 1 | 1 | 2 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 3 | 4 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lipopeptides" by people in Profiles.
-
Efficacy, safety, pharmacokinetics, and associated microbiome changes of ibezapolstat compared with vancomycin in adults with Clostridioides difficile infection: a phase 2b, randomised, double-blind, active-controlled, multicentre study. Lancet Microbe. 2025 Aug; 6(8):101126.
-
Micafungin pharmacodynamics predict clinical outcomes in hospitalized patients with candidemia caused by certain Candida species. Pharmacotherapy. 2023 06; 43(6):466-472.
-
Immune Modulation to Improve Survival of Viral Pneumonia in Mice. Am J Respir Cell Mol Biol. 2020 12; 63(6):758-766.
-
Inducible Epithelial Resistance against Coronavirus Pneumonia in Mice. Am J Respir Cell Mol Biol. 2020 10; 63(4):540-541.
-
Cross-linking Proteomics Indicates Effects of Simvastatin on the TLR2 Interactome and Reveals ACTR1A as a Novel Regulator of the TLR2 Signal Cascade. Mol Cell Proteomics. 2019 09; 18(9):1732-1744.
-
TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion. Proc Natl Acad Sci U S A. 2019 05 21; 116(21):10453-10462.
-
Inducible lung epithelial resistance requires multisource reactive oxygen species generation to protect against bacterial infections. PLoS One. 2019; 14(2):e0208216.
-
Trichosporonosis in Pediatric Patients With a Hematologic Disorder. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):199-204.
-
Uncommon cause of fungemia in a patient with renal cell cancer: A case report of Candida lusitaniae Fungemia. Medicine (Baltimore). 2017 11; 96(45):e8510.
-
Combined aerosolized Toll-like receptor ligands are an effective therapeutic agent against influenza pneumonia when co-administered with oseltamivir. Eur J Pharmacol. 2018 Jan 05; 818:191-197.